Valéria Aoki

Universidade de São Paulo — Brazil

Medicine · Health Sciences

45h-index7.5kcitations278works6.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Autoimmune Bullous Skin Diseases(125), Dermatology and Skin Diseases(94), Urticaria and Related Conditions(58), Coagulation, Bradykinin, Polyphosphates, and Angioedema(55), Allergic Rhinitis and Sensitization(51)

Publications277 total

Perceptions of a Group of Experts on the Integration of Artificial Intelligence in the Management of Atopic Dermatitis
JEADV Clinical Practice·2025Open Access
Penfigoide bolhoso: análise epidemiológica, clínica e terapêutica de 189 pacientes em centro terciário no Brasil
Anais Brasileiros de Dermatologia (Versão em Português)·2025Open Access
Bullous pemphigoid: epidemiological, clinical, and therapeutic analysis of 189 patients in a tertiary center in Brazil
Anais Brasileiros de Dermatologia·2025· 1 citedOpen Access
Achieving Optimal Treatment Targets and Minimal Disease Activity with Upadacitinib for Moderate-to-Severe Atopic Dermatitis: Integrated Analysis of Phase 3 Studies (Measure Up 1 and 2)
Dermatology and Therapy·2025· 1 citedOpen Access
Vias do inflamassoma na dermatite atópica: perspectivas sobre os mecanismos inflamatórios e alvos terapêuticos
Anais Brasileiros de Dermatologia (Versão em Português)·2025Open Access
Heightened Innate Immune and Inflammatory Gene Expression in the Skin of Severe COVID-19 Cases
Journal of Inflammation Research·2025Open Access
Prurido na dermatite atópica: estudo transversal de pacientes adultos de hospital universitário terciário em São Paulo, Brasil
Anais Brasileiros de Dermatologia (Versão em Português)·2025Open Access
Impact of Achieving Optimal Treatment Targets and Minimal Disease Activity on Health-Related Quality of Life and Satisfaction in Patients with Atopic Dermatitis
Dermatology and Therapy·2025· 4 citedOpen Access
Type I Interferons in SARS-CoV-2 Cutaneous Infection: Is There a Role in Antiviral Defense?
International Journal of Molecular Sciences·2025Open Access
Inflammasome pathways in atopic dermatitis: insights into inflammatory mechanisms and therapeutic targets
Anais Brasileiros de Dermatologia·2025· 1 citedOpen Access
O impacto da dermatite atópica na prática clínica: resultados do MEASURE‐AD do Brasil, México e Argentina
Anais Brasileiros de Dermatologia (Versão em Português)·2025Open Access
L’upadacitinib augmente la proportion de patients atteints de dermatite atopique modérée à sévère atteignant l’activité minimale de la maladie : résultats des études de phase 3 (measure up 1 et measure up 2)
Revue française d'allergologie·2025
The real-world burden of atopic dermatitis: MEASURE-AD results from Brazil, Mexico, and Argentina
Anais Brasileiros de Dermatologia·2025· 1 citedOpen Access
Management of Mild‐to‐Moderate Atopic Dermatitis With Topical Treatments by Dermatologists: A Questionnaire‐Based Study
JEADV Clinical Practice·2025· 1 citedOpen Access
Pruritus in atopic dermatitis: a cross-sectional study of adult patients from a tertiary university hospital in São Paulo, Brazil
Anais Brasileiros de Dermatologia·2025· 2 citedOpen Access
Advances in Pemphigus and Pemphigoid: A Report of the International Meeting of the Pemphigus and Pemphigoid Foundation in Thessaloniki, Greece
JID Innovations·2024· 2 citedOpen Access
L’upadacitinib augmente la proportion de patients atteints de dermatite atopique modérée à sévère atteignant l’activité minimale de la maladie : résultats des études de phase 3 (Measure Up 1 et Measure Up 2)
Annales de Dermatologie et de Vénéréologie - FMC·2024
The global reach of artificial intelligence in atopic dermatitis: The quality and reliability of ChatGPT responses in 8 languages
JAAD International·2024· 7 citedOpen Access
A practical guide to using oral Janus kinase inhibitors for atopic dermatitis from the International Eczema Council
British Journal of Dermatology·2024· 30 citedOpen Access
53959 Treatment With Upadacitinib Increases the Achievement of Minimal Disease Activity Among Patients With Moderate-to-Severe Atopic Dermatitis: Results From Phase 3 Studies (Measure Up 1 and Measure Up 2)
Journal of the American Academy of Dermatology·2024· 2 citedOpen Access
page 1 of 14Next →

Frequent Co-authors

Evandro A. Rivitti(19), Luis A. Díaz(16), Günter Hans‐Filho(13), Ning Li(7), Vandir dos Santos(7), Åke Svensson(6), Roberto Takaoka(6), Dédée F. Murrell(5), Cláudia Giuli Santi(5), Celina Wakisaka Maruta(5), Henrique Akira Ishii(5), Kim S Thomas(5), Joanne R Chalmers(5), Bahjat F. Qaqish(5), S. A. P. Sampaio(5), Janet A. Fairley(4), Donna A. Culton(4), Jochen Schmitt(4), Phyllis I. Spuls(4), Christian Apfelbacher(4)